BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 14, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for Jan. 13, 2026

Jan. 13, 2026
Clinical updates, including data readouts and publications: Actuate, Amplia, Benitec, Bioage, BMS, Erasca, Idorsia, In8bio, Johnson & Johnson, Lexeo, Lipocine, Lynk, Medicus, Ocugen, Oncolytics, Oruka, Phanes, Pfizer, Pharmaessentia, Regenxbio, Viking.
Read More

In the clinic for Jan. 13, 2026

Jan. 13, 2026
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Gramatters, Pathmaker Neurosystems, Revital Vision.
Read More

In the clinic for Jan. 13, 2026

Jan. 13, 2026
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Hutchmed, Incyte Biosciences, Kahr Medical, Nanjing Delova Biotech
Read More

In the clinic for Jan. 12, 2026

Jan. 12, 2026
Clinical updates, including data readouts and publications: Acousia, Clarametyx, Eli Lilly, Enyo, Innovent, Krystal, Krystal, Zyus.
Read More

In the clinic for Jan. 9, 2026

Jan. 9, 2026
Clinical updates, including data readouts and publications: Agomab, Antag, Biovaxys, Coya, Enliven, Enterobiotix, Epicrispr, Epirium, Eupraxia, Imbria, Kahr, Renovorx, Reviva, Sobi, Sustained, Tvardi, Virometix.
Read More

In the clinic for Jan. 9, 2026

Jan. 9, 2026
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Omanda Health, Skylinedx.
Read More

In the clinic for Jan. 8, 2026

Jan. 8, 2026
Clinical updates, including data readouts and publications: Bridgebio, Genfit, Gilgamesh, GSK, Hutchmed, Jazz, JJP Biologics, Monte Rosa, Pulmocide, Rezolute.
Read More

In the clinic for Jan. 7, 2026

Jan. 7, 2026
Clinical updates, including data readouts and publications: Aclaris, Actuate, Alumis, Apogee, Arrowhead, Astrazeneca, Bright Minds, Cognition, Compass, Demerx, Encellin, Huyabio, Idorsia, Iksuda, Johnson & Johnson, Metavia, Nanjing Delova, Novabridge, Seres.
Read More

In the clinic for Jan. 7, 2026

Jan. 7, 2026
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sera Prognostics.
Read More

In the clinic for Jan. 6, 2026

Jan. 6, 2026
Clinical updates, including data readouts and publications: Bioinvent, Crinetics, Incyte, Marker, Neumora, Soleno, Zenas.
Read More
Previous 1 2 … 10 11 12 13 14 15 16 17 18 … 326 327 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • Blood sample tubes after centrifuge

    Pre-disease plasma signature may help redefine lung cancer risk

    BioWorld
    Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing